Pandiag, Maila C.
HRN: 12-17-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2022
CEFUROXIME 500MG (TAB)
05/03/2022
05/09/2022
ORAL
500mg/tab
BID
S/P NSVD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes